Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Cross-talk between tumor stem cells and tumor cells: a glioblastoma strategy to promote malignancy.

Riboni L.

Stem Cell Investig. 2018 Oct 10;5:32. doi: 10.21037/sci.2018.09.04. eCollection 2018. No abstract available.

2.

Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.

Li TF, Li K, Wang C, Liu X, Wen Y, Xu YH, Zhang Q, Zhao QY, Shao M, Li YZ, Han M, Komatsu N, Zhao L, Chen X.

J Control Release. 2017 Dec 28;268:128-146. doi: 10.1016/j.jconrel.2017.10.024. Epub 2017 Oct 16.

PMID:
29051064
3.

Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines.

Breznik B, Motaln H, Vittori M, Rotter A, Lah Turnšek T.

Oncotarget. 2017 Apr 11;8(15):25482-25499. doi: 10.18632/oncotarget.16041.

4.

Growth factors from tumor microenvironment possibly promote the proliferation of glioblastoma-derived stem-like cells in vitro.

Guo J, Niu R, Huang W, Zhou M, Shi J, Zhang L, Liao H.

Pathol Oncol Res. 2012 Oct;18(4):1047-57. Epub 2012 Jul 28.

PMID:
22996727
5.

Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells.

Daniele S, Sestito S, Pietrobono D, Giacomelli C, Chiellini G, Di Maio D, Marinelli L, Novellino E, Martini C, Rapposelli S.

ACS Chem Neurosci. 2017 Jan 18;8(1):100-114. doi: 10.1021/acschemneuro.6b00251. Epub 2016 Nov 10.

PMID:
27797168
6.

3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.

Yan H, Romero-López M, Benitez LI, Di K, Frieboes HB, Hughes CCW, Bota DA, Lowengrub JS.

Cancer Res. 2017 Aug 1;77(15):4171-4184. doi: 10.1158/0008-5472.CAN-16-3094. Epub 2017 May 23.

7.

Glioblastoma Stem Cell-Tumor Cell Cross-talk Drives Gliomagenesis.

[No authors listed]

Cancer Discov. 2018 Jun;8(6):OF12. doi: 10.1158/2159-8290.CD-RW2018-062. Epub 2018 Apr 13.

PMID:
29653954
8.

Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.

Motaln H, Koren A, Gruden K, Ramšak Ž, Schichor C, Lah TT.

Oncotarget. 2015 Dec 1;6(38):40998-1017. doi: 10.18632/oncotarget.5701.

9.

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R.

Nature. 2010 Dec 9;468(7325):824-8. doi: 10.1038/nature09557. Epub 2010 Nov 21. Erratum in: Nature. 2011 Sep 8;477(7363):238. Nature. 2011 Jan 20;469(7330):432.

PMID:
21102434
10.

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.

Mishra P, Banerjee D, Ben-Baruch A.

J Leukoc Biol. 2011 Jan;89(1):31-9. doi: 10.1189/jlb.0310182. Epub 2010 Jul 13. Review.

PMID:
20628066
11.

Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Zeniou M, Fève M, Mameri S, Dong J, Salomé C, Chen W, El-Habr EA, Bousson F, Sy M, Obszynski J, Boh A, Villa P, Assad Kahn S, Didier B, Bagnard D, Junier MP, Chneiweiss H, Haiech J, Hibert M, Kilhoffer MC.

PLoS One. 2015 Aug 13;10(8):e0134793. doi: 10.1371/journal.pone.0134793. eCollection 2015.

12.

Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.

Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski SM, Hamerlik P, Mack SC, Bao S, Rich JN.

Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.

PMID:
29625067
13.

CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.

Chiao MT, Yang YC, Cheng WY, Shen CC, Ko JL.

Curr Neurovasc Res. 2011 Aug 1;8(3):210-9.

PMID:
21675958
14.

Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration.

Sciaccaluga M, D'Alessandro G, Pagani F, Ferrara G, Lopez N, Warr T, Gorello P, Porzia A, Mainiero F, Santoro A, Esposito V, Cantore G, Castigli E, Limatola C.

PLoS One. 2013 Sep 2;8(9):e73426. doi: 10.1371/journal.pone.0073426. eCollection 2013.

15.

Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes.

Caspani EM, Crossley PH, Redondo-Garcia C, Martinez S.

PLoS One. 2014 Jul 17;9(7):e101402. doi: 10.1371/journal.pone.0101402. eCollection 2014.

16.

Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.

Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, Wang JM.

Cancer Res. 2007 Jun 15;67(12):5906-13.

17.
18.

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.

Podergajs N, Motaln H, Rajčević U, Verbovšek U, Koršič M, Obad N, Espedal H, Vittori M, Herold-Mende C, Miletic H, Bjerkvig R, Turnšek TL.

Oncotarget. 2016 Jan 5;7(1):593-609. doi: 10.18632/oncotarget.5477.

19.

Glioblastoma stem cells: a new target for metformin and arsenic trioxide.

Carmignani M, Volpe AR, Aldea M, Soritau O, Irimie A, Florian IS, Tomuleasa C, Baritchii A, Petrushev B, Crisan G, Valle G.

J Biol Regul Homeost Agents. 2014 Jan-Mar;28(1):1-15. Review.

PMID:
24750786
20.

Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance.

Skjellegrind HK, Fayzullin A, Johnsen EO, Eide L, Langmoen IA, Moe MC, Vik-Mo EO.

Neurochem Res. 2016 Jul;41(7):1545-58. doi: 10.1007/s11064-016-1868-2. Epub 2016 Feb 25.

Supplemental Content

Support Center